Skip to main content

SENSIENT TECHNOLOGIES CORP

For the period ended Sep 30, 2026. Filed Oct 30, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 30, 2026

SXT$121.68+2.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Consolidated Condensed Financial Statements

Accounting Policies

In the opinion of Sensient Technologies Corporation (the Company), the accompanying unaudited consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) that are necessary to present fairly the financial position of the Company as of September 30, 2026, and the results of operations, comprehensive income, and shareholders’ equity for the three and nine months ended September 30, 2026 and 2025, and cash flows for the nine months ended September 30, 2026 and 2025. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full year.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Expenses are charged to operations in the period incurred.

Recently Adopted Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. This ASU also requires the Company to disaggregate its income taxes paid disclosure by federal, state, and foreign taxes, with further disaggregation required for significant individual jurisdictions. This ASU is effective for fiscal years beginning after December 15, 2024. The Company adopted this ASU in the fourth quarter of 2025 using a prospective transition method. The Company updated its annual disclosures as a result of adopting this ASU, and the adoption did not have a material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In November 2024, the FASB issued ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) – Disaggregation of Income Statement Expenses, which will require the Company to disclose disaggregated information about certain income statement expense line items. This ASU is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and its related disclosures.

Please refer to the notes in the Company’s annual consolidated financial statements for the year ended December 31, 2025, for additional details of the Company’s financial condition and a description of the Company’s accounting policies, which have been continued without change.

  1. Acquisition

On February 14, 2025, the Company acquired Biolie SAS, a natural color extraction business located in France. The Company paid $4.9 million in cash for this acquisition, which is net of $0.2 million in debt assumed. The assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. The Company acquired net assets of $0.3 million, with the remaining $4.6 million allocated to goodwill. This business is part of the Color segment.

  1. Portfolio Optimization Plan

During the fourth quarter of 2023, the Board of Directors of the Company approved a plan to undertake an effort to optimize certain production facilities and improve efficiencies within the Company (Portfolio Optimization Plan). As part of the Portfolio Optimization Plan, in the Flavors & Extracts segment, the Company evaluated the closure of its manufacturing facility in Felinfach, Wales, United Kingdom, the closure of its sales office in Granada, Spain, and the centralization and elimination of certain selling and administrative positions. In addition, in the Color segment, the Company evaluated the closure of a manufacturing facility in Delta, British Columbia, Canada, the closure of a sales office in Argentina, and centralizing and eliminating certain production positions and selling and administrative positions. The Company reports all costs associated with the Portfolio Optimization Plan in the Corporate & Other segment.

Index

The Company’s Felinfach site was shut down in May 2025, and all production activities have been transferred to other locations. The Company began marketing the Felinfach site for sale in June 2025, at which point the held for sale criteria were met. These are the sole assets recorded in Fixed assets held for sale on the Company’s Consolidated Balance Sheet at December 31, 2025. The Company sold the land and building assets in February 2026 for approximately $2.0 million, resulting in a $0.4 million gain recognized in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings during the three months ended March 31, 2026. There wereno costs associated with the Portfolio Optimization Plan recognized during the three or nine months ended September 30, 2026. The Company has completed all actions contemplated under the Portfolio Optimization Plan.

The total cost of the Portfolio Optimization Plan was approximately $50 million, primarily related to non-cash impairment charges and employee separation costs. We anticipate that the Portfolio Optimization Plan will reduce annual operating costs by approximately $8 million, with the full benefit expected to be achieved beginning in 2026. The Company reduced headcount by approximately 100 positions, primarily in the Flavors & Extracts and Color segments, related to certain production and selling and administrative positions.

The following table summarizes the Portfolio Optimization Plan expenses by segment for the three months ended September 30, 2025:

(In thousands) · Flavors & Extracts · Color · Consolidated
Non-cash impairment charges – Selling and administrative expenses$584$-$584
Non-cash charges – Cost of products sold249-249
Employee separation – Selling and administrative expenses16-16
Other production costs – Cost of products sold400-400
Other costs – Selling and administrative expenses (1)1,9551192,074
Total$3,204$119$3,323

(1)

Other costs include professional services, decommissioning costs, and other related costs.

The following table summarizes the Portfolio Optimization Plan expenses by segment for the nine months ended September 30, 2025:

(In thousands) · Flavors & Extracts · Color · Corporate & Other · Consolidated
Non-cash impairment charges – Selling and administrative expenses$701$-$-$701
Non-cash charges – Cost of products sold1,430--1,430
Employee separation – Selling and administrative expenses4968-504
Other production costs – Cost of products sold2,822--2,822
Other costs – Selling and administrative expenses (1)3,6832211654,069
Total$9,132$229$165$9,526

(1)

Other costs include professional services, decommissioning costs, and other related costs.

Trade Accounts Receivable

Trade accounts receivables are recorded at their face amount, less an allowance for expected losses on doubtful accounts. The allowance for doubtful accounts is calculated based on customer-specific analysis and an aging methodology using historical loss information. The Company believes historical loss information is a reasonable basis for expected credit losses as the Company’s historical credit loss experience correlates with its customer delinquency status. This information is also adjusted for any known current economic conditions. Forecasted economic conditions have not had a significant impact on the current credit loss estimate due to the short-term nature of the Company’s customer receivables; however, the Company will continue to monitor and evaluate the rapidly changing economic conditions. Additionally, as the Company only hasone portfolio segment, there are not different risks between portfolios. Specific accounts are written off against the allowance for doubtful accounts when the receivable is deemed no longer collectible.

Index

The following table summarizes the changes in the allowance for doubtful accounts during the three and nine month periods ended September 30, 2026 and 2025:

(In thousands) Three Months Ended September 30, 2026Allowance for Doubtful Accounts
Balance at June 30, 2026$5,118
Provision for expected credit losses35
Accounts written off(111)
Translation and other activity(20)
Balance at September 30, 2026$5,022
(In thousands) Three Months Ended September 30, 2025Allowance for Doubtful Accounts
Balance at June 30, 2025$5,612
Provision for expected credit losses120
Accounts written off(344)
Translation and other activity1
Balance at September 30, 2025$5,389
(In thousands) Nine Months Ended September 30, 2026Allowance for Doubtful Accounts
Balance at December 31, 2025$5,128
Provision for expected credit losses532
Accounts written off(612)
Translation and other activity(26)
Balance at September 30, 2026$5,022
(In thousands) Nine Months Ended September 30, 2025Allowance for Doubtful Accounts
Balance at December 31, 2024$5,023
Provision for expected credit losses864
Accounts written off(809)
Translation and other activity311
Balance at September 30, 2025$5,389

Inventories

At September 30, 2026, and December 31, 2025, inventories included finished and in-process products totaling $551.9 million and $491.4 million, respectively, and raw materials and supplies of $239.2 million and $186.8 million, respectively.

Debt

On March 27, 2026, the Company issued €65 million of Euro-denominated senior notes under the Amended and Restated Consolidated Note Purchase and Master Note Agreement, maturing in March 2030 and bearing an interest rate of 4.00%. The proceeds were used to repay a portion of the Company’s existing revolving credit facility.

On June 18, 2026, the Company entered into a Credit Agreement (Credit Agreement) with CoBank, ACB, and the lenders party thereto from time to time. The Credit Agreement provides for an unsecured delayed-draw term loan credit facility (Term Loan) in the aggregate principal amount of up to $400 million, which is to be drawn in up tofive advances over fifteen months following the closing date. All amounts owing under the Term Loan will be duefive years from the closing date. Proceeds from the Credit Agreement will be used to refinance existing indebtedness and for working capital and other general corporate purposes. There was $100 million outstanding on the Term Loan as of September 30, 2026.

On August 31, 2026, the Company entered into Omnibus Amendment No. 1 (Receivables Amendment) to the Receivables Purchase Agreement, dated October 3, 2016. The Receivables Amendment amends the Receivables Purchase Agreement to, among other things, (i) add PNC Bank, National Association as a purchaser and the administrative agent under the Receivables Securitization Program, (ii) increase the facility limit from $105 million to $115 million, and (iii) extend the termination date of the Receivables Securitization Program from August 31, 2026 to August 30, 2027. The amount was fully drawn as of September 30, 2026.

Index

Fair Value

Accounting Standards Codification 820, Fair Value Measurement, defines fair value for financial assets and liabilities, establishes a framework for measuring fair value in GAAP, and expands disclosures about fair value measurements. The carrying values of the Company’s cash and cash equivalents, trade accounts receivable, trade accounts payable, accrued expenses, and short-term borrowings were approximately the same as the fair values as of September 30, 2026 and December 31, 2025. The net fair value of the forward exchange contracts based on current pricing obtained for comparable derivative products (Level 2 inputs) was an asset of $0.4 million and $0.3 million as of September 30, 2026 and December 31, 2025, respectively. The fair value of the Company’s long-term debt, including the portions of long-term debt classified as Short-term borrowings on the Company’s Consolidated Balance Sheets, is estimated using discounted cash flows based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements (Level 2 inputs). The carrying value of the long-term debt at September 30, 2026 and December 31, 2025, was $790.3 million and $709.5 million, respectively. The fair value of the long-term debt at September 30, 2026 and December 31, 2025, was $791.4 million and $720.9 million, respectively.

Segment Information

The Company evaluates performance based on operating income before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders); restructuring and other charges, including Portfolio Optimization Plan costs; interest expense; and income taxes (segment operating income). Total revenue and segment operating income by business segment and geographic region include both sales to customers, as reported in the Company’s Consolidated Statements of Earnings, and intersegment sales, which are accounted for at prices that approximate market prices and are eliminated in consolidation.

Assets by business segment and geographic region are those assets used in the Company’s operations in each segment and geographic region. Segment assets reflect the allocation of goodwill to each segment. Corporate & Other assets consist primarily of accounts receivables from the securitization program, investments, deferred tax assets, and fixed assets.

The Company determines its operating segments based on information utilized by its chief operating decision maker (CODM) to allocate resources and assess performance. The Company’s CODM is the President and Chief Executive Officer. The CODM uses segment operating income or loss to allocate resources, which includes employee, financial, or capital resources, predominantly in the annual budget and forecasting process. The CODM considers budget-to-actual and year-over-year variances on a monthly basis for segment operating income or loss when allocating capital and personnel resources to the segments. Segment performance is evaluated based on operating income of the respective business units before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders), restructuring and other charges, including Portfolio Optimization Plan costs, and other costs (which are reported in Corporate & Other), interest expense, and income taxes.

The Company’sthree reportable segments are the Flavors & Extracts and Color segments, which are both managed on a product line basis, and the Asia Pacific segment, which is managed on a geographic basis. The Company’s Flavors & Extracts segment produces flavor, extracts, and essential oils products that impart a desired taste, texture, aroma, or other characteristics to a broad range of consumer and other products. The Color segment produces natural and synthetic color systems for foods, beverages, pharmaceuticals, and nutraceuticals; colors, ingredients, and systems for personal care; and technical colors for industrial applications. The Asia Pacific segment is managed on a geographic basis and produces and distributes color, flavor, and essential oils products for the Asia Pacific countries. The Company’s corporate expenses, share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders), restructuring and other charges, including Portfolio Optimization Plan costs as further described in Note 3, Portfolio Optimization Plan, and certain other costs are included in the “Corporate & Other” category.

Index

Operating results by segment for the periods presented are as follows:

(In thousands) · Flavors & Extracts · Color · Asia Pacific · Corporate& Other · Consolidated
Three months ended September 30, 2026:
Total segment revenue$209,973$210,343$47,304$-$467,620
Intersegment revenue(6,136)(5,400)(243)-(11,779)
Consolidated revenue from external customers203,837204,94347,061-455,841
Cost of products sold146,313118,94525,635-290,893
Selling and administrative expense27,00539,9449,06216,48892,499
Operating income (loss)30,51946,05412,364(16,488)72,449
Interest expense8,345
Earnings before income taxes$64,104
Assets954,8131,039,324142,654339,0412,475,832
Capital expenditures11,50423,7196812,35838,262
Depreciation and amortization8,1316,5125801,02916,252
Three months ended September 30, 2025:
Total segment revenue$202,970$178,156$42,082$-$423,208
Intersegment revenue(5,973)(4,995)(131)-(11,099)
Consolidated revenue from external customers196,997173,16141,951-412,109
Cost of products sold143,055102,82824,235649270,767
Selling and administrative expense25,90432,5998,17516,95883,636
Operating income (loss)28,03837,7349,541(17,607)57,706
Interest expense7,328
Earnings before income taxes$50,378
Assets884,996886,367129,655308,5232,209,541
Capital expenditures10,6487,1965841,32519,753
Depreciation and amortization7,7366,24960496715,556
(In thousands) · Flavors &Extracts · Color · Asia Pacific · Corporate& Other · Consolidated
Nine months ended September 30, 2026:
Total segment revenue$624,977$624,656$140,148$-$1,389,781
Intersegment revenue(20,376)(15,199)(450)-(36,025)
Consolidated revenue from external customers604,601609,457139,698-1,353,756
Cost of products sold435,421350,25277,648863,321
Selling and administrative expense81,480116,57227,54648,960274,558
Operating income (loss)87,700142,63334,504(48,960)215,877
Interest expense24,421
Earnings before income taxes$191,456
Assets954,8131,039,324142,654339,0412,475,832
Capital expenditures35,71762,7321,6745,652105,775
Depreciation and amortization23,80219,0361,7433,09947,680
Nine months ended September 30, 2025:
Total segment revenue$599,902$525,188$126,727$-$1,251,817
Intersegment revenue(17,626)(15,319)(208)-(33,153)
Consolidated revenue from external customers582,276509,869126,519-1,218,664
Cost of products sold423,614301,02773,8204,252802,713
Selling and administrative expense77,12997,33424,77347,773247,009
Operating income (loss)81,533111,50827,926(52,025)168,942
Interest expense22,060
Earnings before income taxes$146,882
Assets884,996886,367129,655308,5232,209,541
Capital expenditures37,65515,6771,1883,26857,788
Depreciation and amortization23,05218,2471,7222,86945,890

Index

Product Lines

(In thousands) · Flavors & Extracts · Color · Asia Pacific · Consolidated
Three months ended September 30, 2026:
Flavors, Extracts & Flavor Ingredients$139,110$-$-$139,110
Agricultural Ingredients70,863--70,863
Food & Pharmaceutical Colors-164,457-164,457
Personal Care-45,886-45,886
Asia Pacific--47,30447,304
Intersegment Revenue(6,136)(5,400)(243)(11,779)
Total revenue from external customers$203,837$204,943$47,061$455,841
Three months ended September 30, 2025:
Flavors, Extracts & Flavor Ingredients$136,831$-$-$136,831
Agricultural Ingredients66,139--66,139
Food & Pharmaceutical Colors-133,548-133,548
Personal Care-44,608-44,608
Asia Pacific--42,08242,082
Intersegment Revenue(5,973)(4,995)(131)(11,099)
Total revenue from external customers$196,997$173,161$41,951$412,109
(In thousands) · Flavors & Extracts · Color · Asia Pacific · Consolidated
Nine months ended September 30, 2026:
Flavors, Extracts & Flavor Ingredients$424,287$-$-$424,287
Agricultural Ingredients200,690--200,690
Food & Pharmaceutical Colors-483,478-483,478
Personal Care-141,178-141,178
Asia Pacific--140,148140,148
Intersegment Revenue(20,376)(15,199)(450)(36,025)
Total revenue from external customers$604,601$609,457$139,698$1,353,756
Nine months ended September 30, 2025:
Flavors, Extracts & Flavor Ingredients$408,748$-$-$408,748
Agricultural Ingredients191,154--191,154
Food & Pharmaceutical Colors-394,525-394,525
Personal Care-130,663-130,663
Asia Pacific--126,727126,727
Intersegment Revenue(17,626)(15,319)(208)(33,153)
Total revenue from external customers$582,276$509,869$126,519$1,218,664

Geographic Markets

(In thousands)Flavors & ExtractsColorAsia PacificConsolidated
Three months ended September 30, 2026:
North America$165,877$113,241$2$279,120
Europe27,93952,963-80,902
Asia Pacific2,88317,32345,39965,605
Other7,13821,4161,66030,214
Total revenue from external customers$203,837$204,943$47,061$455,841
Three months ended September 30, 2025:
North America$154,755$84,367$41$239,163
Europe31,82450,270982,103
Asia Pacific3,74316,77441,48362,000
Other6,67521,75041828,843
Total revenue from external customers$196,997$173,161$41,951$412,109

Index

(In thousands)Flavors & ExtractsColorAsia PacificConsolidated
Nine months ended September 30, 2026:
North America$485,071$321,977$94$807,142
Europe90,353166,76517257,135
Asia Pacific10,26056,964135,087202,311
Other18,91763,7514,50087,168
Total revenue from external customers$604,601$609,457$139,698$1,353,756
Nine months ended September 30, 2025:
North America$456,674$247,438$56$704,168
Europe93,265148,67947241,991
Asia Pacific12,98750,448123,325186,760
Other19,35063,3043,09185,745
Total revenue from external customers$582,276$509,869$126,519$1,218,664

Retirement Plans

The Company’s components of annual benefit cost for the defined benefit plans for the periods presented are as follows:

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
(In thousands)2026202520262025
Service cost$307$381$933$1,126
Interest cost4654611,3531,360
Expected return on plan assets(278)(280)(834)(821)
Settlement income(276)-(276)-
Recognized actuarial gain(33)(70)(111)(213)
Total defined benefit expense$185$492$1,065$1,452

The Company’s non-service cost portion of defined benefit expense is recorded in Interest Expense on the Company’s Consolidated Statements of Earnings. The Company’s service cost portion of defined benefit expense is recorded in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings.

Derivative Instruments and Hedging Activity

The Company may use forward exchange contracts and foreign currency denominated debt to manage its exposure to foreign exchange risk in order to reduce the effect of fluctuating foreign currencies on short-term foreign currency denominated intercompany transactions, non-functional currency raw material purchases, non-functional currency sales, and other known foreign currency exposures. These forward exchange contracts generally have maturities of less than 18 months. The Company’s primary hedging activities and their accounting treatment are summarized below.

Forward exchange contracts– Certain forward exchange contracts have been designated as cash flow hedges. The Company had $29.3 million and $49.9 million of forward exchange contracts designated as cash flow hedges outstanding as of September 30, 2026 and December 31, 2025, respectively. For the three months ended September 30, 2026 and 2025, the amounts reclassified into net earnings in the Company’s Consolidated Statements of Earnings that offset the underlying transactions’ impact on earnings in the same period werenot material. For each of the nine months ended September 30, 2026 and 2025, a gain of $1.1 million was reclassified into net earnings in the Company’s Consolidated Statements of Earnings that offset the underlying transactions’ impact on earnings in the same period. In addition, the Company utilizes forward exchange contracts that are not designated as cash flow hedges. The results of these transactions were not material to the financial statements of the Company.

Index

Net investment hedges – The Company has designated certain foreign currency denominated long-term borrowings as partial hedges of the Company’s foreign currency net asset positions. As of September 30, 2026 and December 31, 2025, the total value of the Company’s net investment hedges, which included Euro denominated long-term debt, was $298.6 million and $309.5 million, respectively. Changes in the fair value of this debt attributable to changes in the spot foreign exchange rate are recorded in foreign currency translation in Other Comprehensive Loss(OCL). For the three months ended September 30, 2026 and 2025, the impact of foreign exchange rates on these debt instruments decreased debt by $2.4 million and $2.1 million, respectively, which has been recorded as foreign currency translation in OCL. For the nine months ended September 30, 2026 and 2025, the impact of foreign exchange rates on these debt instruments decreased debt by $10.9 million and increased debt by $37.5 million, respectively, which has been recorded as foreign currency translation in OCL.

Income Taxes

The effective income tax rates for the three months ended September 30, 2026 and 2025 were 24.6% and 26.6%, respectively. For the nine months ended September 30, 2026 and 2025, the effective income tax rates were 24.9% and 25.8%, respectively. The effective tax rates for the three and nine months ended September 30, 2026 and 2025 were impacted by the mix of foreign earnings and changes in estimates associated with the finalization of prior year foreign tax items. The effective tax rates for the three and nine months ended September 30, 2025 were further impacted by the limited tax deductibility of costs related to the Portfolio Optimization Plan.

Accumulated Other Comprehensive Loss

The following table summarizes the changes in OCL during the three and nine month periods ended September 30, 2026 and 2025:

(In thousands)Cash Flow Hedges (1)Pension Items (1)Foreign Currency ItemsTotal
Balances at December 31, 2025$30$(3,392)$(166,891)$(170,253)
Other comprehensive income (loss) before reclassifications1,432-(9,585)(8,153)
Amounts reclassified from OCL(1,084)(82)-(1,166)
Balances at September 30, 2026$378$(3,474)$(176,476)$(179,572)
(In thousands)Cash Flow Hedges (1)Pension Items (1)Foreign Currency ItemsTotal
Balances at June 30, 2026$952$(3,450)$(168,593)$(171,091)
Other comprehensive loss before reclassifications(137)-(7,883)(8,020)
Amounts reclassified from OCL(437)(24)-(461)
Balances at September 30, 2026$378$(3,474)$(176,476)$(179,572)
(In thousands)Cash FlowHedges (1)PensionItems (1)Foreign Currency ItemsTotal
Balances at December 31, 2024$(310)$(2,348)$(224,181)$(226,839)
Other comprehensive income before reclassifications1,946-52,32154,267
Amounts reclassified from OCL(1,113)(159)-(1,272)
Balances at September 30, 2025$523$(2,507)$(171,860)$(173,844)
(In thousands)Cash FlowHedges (1)PensionItems (1)Foreign Currency ItemsTotal
Balances at June 30, 2025$723$(2,455)$(171,747)$(173,479)
Other comprehensive income (loss) before reclassifications222-(113)109
Amounts reclassified from OCL(422)(52)-(474)
Balances at September 30, 2025$523$(2,507)$(171,860)$(173,844)

(1)

Cash Flow Hedges and Pension Items are net of tax.

Index

Commitments and Contingencies

The Company is subject to various claims and litigation arising in the normal course of business. The Company establishes reserves for claims and proceedings when it is probable that liabilities exist, and reasonable estimates of loss can be made. While it is not possible to predict the outcome of these matters, based on our assessment of the facts and circumstances now known, we do not believe that these matters, individually or in the aggregate, will have a material adverse effect on our financial position. However, actual outcomes may be different from those expected and could have a material effect on our results of operations or cash flows in a particular period.

Subsequent Event

On October 29, 2026, the Company announced its quarterly dividend of $0.41 per share would be payable on December 1, 2026.

Index

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.